openPR Logo
Press release

Global Revenues For The Immunology Market Are Forecast To Grow At A CAGR Of 3.63%, To $74.1 Billion In 2022

11-28-2017 10:29 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Researchmoz.us

Immunology Drugs Market

Immunology Drugs Market

Researchmoz added Most up-to-date research on "Global Immunology Drugs Market to 2022 - Increasing Prevalence, Repositioning Opportunities and Strong Uptake of Interleukin Receptor Inhibitors to Drive Growth" to its huge collection of research reports.

Immunology is a therapy area characterized by disorders of the immune system, specifically an aberrant autoimmune response against healthy tissues in the body, leading to chronic or acute inflammation. Depending on the specific site affected, this can lead to various types of chronic pain and mobility loss, and have a negative impact on quality of life.

A number of therapies have been approved for immunological disorders, including the largely genericized disease-modifying anti-rheumatic drug (DMARD) class of small molecule drugs. However, as these therapies often fail to elicit an adequate long-term response, a large second-line therapy segment has emerged in these markets, beginning with the approval of Remicade (infliximab) and Enbrel (etanercept) in 1998. There is currently no cure for immunological disorders due to the highly complex nature of the immune system and the fact that many components of the pathophysiological states of these diseases have roles in the healthy immune system.

To Get Sample Copy of Report visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=1160848

Autoimmune disorders are currently incurable, and treatment is aimed at managing the disease, in order to reduce the severity of its symptoms and lower the risk of associated co-morbidities. Cytokines and their receptors, such as Tumor Necrosis Factor-? and Interleukin-6 are the most effective and most common therapies used in immunology. This class of compounds has been the most commercially successful in the past decade, particularly in the RA market, with many clinical trials underway across various immunological indications. The market for immunological disorders is largely accounted for by premium products, with only a relatively small revenue share accounted for by generics and biosimilars.

Inflectra, a biosimilar of Remicade was recently approved by the FDA in 2016. However, the gradual uptake of biosimilars such as Inflectra is not expected to act as a strong growth driver for the biosimilar segment within the forecast period. This therefore means existing products such as Remicade are expected to maintain high revenues during the forecast period

Although there is a high degree of failure and uncertainty in R&D of immunological drugs, there are 2,054 drugs in active development in the immunology pipeline. In the long-term, this is expected to drive growth in this market in spite of the anticipated approval of biosimilars for key blockbuster drugs and resultant erosion of revenues. Cytokines and their receptors account for the largest single segment of each of the pipelines which make up the largest individual class.

The report focuses on four key indications within immunology: Rheumatoid arthritis, Systemic lupus erythematosus (SLE), Psoriasis and Inflammatory bowel disease (The two major types of Inflammatory bowel disease covered in this report are Ulcerative colitis and Crohn’s disease). With no curative therapies available, symptomatic medications prescribed off-label are an important part of the treatment paradigm, especially in SLE, increasing the need for extensive R&D within this area.

Get Complete TOC With Tables and Figures @ https://www.researchmoz.us/global-immunology-drugs-market-to-2022-increasing-prevalence-repositioning-opportunities-and-strong-uptake-of-interleukin-receptor-inhibitors-to-drive-growth-report.html/toc

Scope

- Global revenues for the immunology market are forecast to grow at a compound annual growth rate of 3.63%, from $57.7 billion in 2015 to $74.1 billion in 2022.
- Which drugs will achieve blockbuster status and how will the key player companies perform during the forecast period?
- The immunological disorders pipeline is large and diverse, and contains 2,054 products. How does the composition of the pipeline compare with that of the existing market?
- What molecular targets and molecule types are most commonly being trialed in pipeline products in the key indications?
- Which products will contribute to market growth most significantly, and which will achieve blockbuster status?
- Will the current market leaders retain their dominance over the forecast period, and how is their revenue share of the immunology market set to change?

Reasons to buy

- Understand the current clinical and commercial landscape by considering disease pathogenesis, diagnosis, prognosis, and the treatment options available at each stage of diagnosis
- Visualize the composition of the immunology market across each indication, in terms of dominant molecule types and targets, highlighting the key commercial assets and players
- Analyze the immunological disorders pipeline and stratify by stage of development, molecule type and molecular target, with a granular breakdown across key indications
- Understand the growth in patient epidemiology and market revenues for the immunology market, globally and across the key players and product types
- Stratify the market in terms of the split between generic and premium products, and assess the role of these product types in the treatment of the various immunological disorders.
- Identify commercial opportunities in the immunology deals landscape by analyzing trends in licensing and co-development deals

Make an Enquiry of this report @ https://www.researchmoz.us/enquiry.php?type=E&repid=1160848

About ResearchMoz

ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

ResearchMoz
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Email: sales@researchmoz.us
Website @ https://www.researchmoz.us/
Tel: 866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-621-2074
Follow us on LinkedIn @ http://bit.ly/1TBmnVG

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Revenues For The Immunology Market Are Forecast To Grow At A CAGR Of 3.63%, To $74.1 Billion In 2022 here

News-ID: 834716 • Views:

More Releases from Researchmoz.us

Bicycle Tires Market - Substantial Rise in Industrial Sectors to Offer Growth Prospects by 2020-2030
Bicycle Tires Market - Substantial Rise in Industrial Sectors to Offer Growth Pr …
A recent market study published by ResearchMoz on the Global Bicycle Tires market includes industry analysis for 2015-2019 & opportunity assessment for 2020-2030, and delivers a comprehensive assessment of the most important market dynamics. After conducting thorough research on the historical and current growth parameters of the Global Bicycle Tires market, the growth prospects of the market are obtained with maximum precision. Request Sample Copy of Research Report @ https://www.researchmoz.us/enquiry.php?type=S&repid=3074346 Chapter 01
Sports And Athletic Insole Market Overview, Cost Structure Analysis, Growth Opportunities and Forecast to 2020-2030
05-19-2021 | Sports
researchmoz.us
Sports And Athletic Insole Market Overview, Cost Structure Analysis, Growth Oppo …
A recent market study published by ResearchMoz on the sports and athletic insole market offers global industry analysis for 2015-2019 & opportunity assessment for 2020-2030. The study offers a comprehensive assessment of the most important market dynamics. After conducting a thorough research on the historical, as well as current growth parameters, the growth prospects of the market are obtained with maximum precision. Request Sample Copy of Research Report @ https://www.researchmoz.us/enquiry.php?type=S&repid=3074345 Chapter 01
Clean Label Pectin Market Development Status, Size, Share, Growth and Forecast Report To 2026
Clean Label Pectin Market Development Status, Size, Share, Growth and Forecast R …
A recent market study published by ResearchMoz on the Clean Label Pectin Market offers global industry analysis for 2014-2019 & opportunity assessment for 2020–2028. The study offers a comprehensive assessment of the most important market dynamics. After conducting a thorough research on the historical, as well as current growth parameters, the growth prospects of the market are obtained with maximum precision. Request Sample Copy of Research Report @ https://www.researchmoz.us/enquiry.php?type=S&repid=3069625 Market Segmentation The global
Citrus Yogurt Market Growth, Demand, And Value Is Increasing In The Upcoming Years 2020-2030
Citrus Yogurt Market Growth, Demand, And Value Is Increasing In The Upcoming Yea …
A recent market study published by ResearchMoz on Citrus Yogurt market offers global industry analysis for 2014-2019 & opportunity assessment for 2020–2028. The study offers a comprehensive assessment of most important market dynamics. After conducting a thorough research on historical, as well as current growth parameters, the growth prospects of market are obtained with maximum precision. Request Sample Copy of Research Report @ https://www.researchmoz.us/enquiry.php?type=S&repid=3067560 Chapter 01 - Executive Summary The executive summary of

All 5 Releases


More Releases for Immunology

Alta DiagnoTech Releases ELISA Kits for IVD Immunology Testing
Alta DiagnoTech announced the release of its highly sensitive and reliable ELISA kits specifically designed for IVD in immunology testing. New York, USA - January 31, 2025 - As a top supplier of clinical diagnostic products, Alta DiagnoTech introduced ELISA (Enzyme-Linked Immunosorbent Assay) kits designed for in vitro diagnostics (IVD) applications in immunology testing due to their high sensitivity and reliability. Through this initiative Alta DiagnoTech intends to boost diagnostic performance
Empowering Immunology: Creative Biolabs' Streamlined Pathway for IgE Antibodies
The success of their efforts to utilize the power of antibody engineering technologies has now permitted Creative Biolabs to include the anti-IgE antibody among its offerings. New York, USA - November 13, 2024 - The current situation leads us to believe that the value of IgE antibodies [https://non-igg-ab.creative-biolabs.com/category-ige-344.htm] in immunology research has grown significantly. "What makes IgE antibodies fascinating is the fact that they not only identify the pathological mechanisms of
Immunology Drugs Market Research Report 2023 | InsightAce Analytic
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Global Immunology Drugs Market By Drug Class (Monoclonal antibodies, Fusion Proteins, Immunosuppressants, Polyclonal antibodies, and Other Drug classes), Distribution Channel(Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), Disease Indications (Rheumatoid Arthritis, Psoriatic Arthritis, Plaque Psoriasis, Ankylosing Spondylitis, Inflammatory Bowel Disease, and Other disease Indication))- Trends, Industry Competition Analysis, Revenue and Forecast To 2030." According to the
Immunology Market - Shaping the Immune Landscape: Transforming Healthcare with C …
Newark, New Castle, USA - new report, titled Immunology Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Immunology market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Immunology market. The report offers an overview of the market, which briefly describes the
Immunology Biosimilars Market Boosting the Healthcare Industry Worldwide
A biosimilar medicine possesses similar pharmacokinetic and mode of action as an original biological medicine that has already been approved for therapeutic use. Biosimilars are made from a living organism such as bacteria and yeast or can also be derived from small molecules such as human insulin, erythropoietin, and monoclonal antibodies via recombinant DNA and gene expression technologies. Biosimilars are developed only when original biological medicines are commercially expired and
16th International Conference on European Immunology
Meet leading Immunology Experts, Immunity Health Speakers, Immunologist Researchers, Neuro Immunology Scientists from Amsterdam, Netherlands, New York, Valencia, Frankfurt, London, Dubai, Chicago, France, China, all over the world at European Immunology Conference 2022| May 02-03, 2022 Zurich, Switzerland 35 Ruddlesway, Windsor, Berkshire, SL4 5SF Meet leading Immunology Experts, Immunity Health Speakers, Immunologist Researchers, Neuro Immunology Scientists from Amsterdam, Netherlands, New York, Valencia, Frankfurt, London, Dubai, Chicago, France,